Global Penicillin and Streptomycin Market Research and Analysis 2015 - 2022

  • ID: 4196583
  • Report
  • Region: Global
  • Orion Market Research Private Limited
1 of 5

FEATURED COMPANIES

  • Abbot Laboratories
  • Astra Zeneca
  • Bristol Myers Squibb Co.
  • Gilead Sciences Inc.
  • Merck & Co., Inc.
  • Roche Pharmaceuticals
  • MORE

Market Insights

The global Penicillin and Streptomycin market is estimated to grow at a CAGR of 0.5% from 2017-2022.

Penicillin and streptomycin are two of the most widely prescribed antibiotics globally. These antibiotics are capable of preventing bacterial growth. According to the report, various factors responsible for market growth include increasing number of contagious diseases and heavy investments in research and development. Increasing demand for generic drugs is also adding to the market growth. the Penicillin and Streptomycin market has growth opportunities with innovations in new product development and usage of penicillin-streptomycin compound in cell culture as anti-bacterial agent.

However, government regulations and patent expiry issues are major challenges to the growth of the market. Increasing incidences of anti-microbial resistance are also impeding the growth of the market New antibiotics have been developed and used with lesser side effects compared to penicillin and streptomycin which has affected the market of penicillin and streptomycin. The market is segmented on the basis of product type (bulk and dosage), manufacturing process (synthetic process, natural process, semi-synthetic process and natural process) and route of administration (oral, intravenous and intramuscular). the end users include hospitals, clinics and others.

Geographical Insights

Geographically, Asia Pacific holds the maximum of market share is expected to be the largest market for penicillin and streptomycin drugs during the forecasted period. The market is majorly driven by high level of infections due to lack of proper infrastructure and cleanliness. The market is also dominated by some of the world’s largest generic drug manufacturers which are also dominating the penicillin and streptomycin production. The market is then dominated by North American region and Europe. These market are highly developed with high level of awareness regarding infectious diseases caused by bacteria, proper healthcare infrastructure and government regulations.

The report includes detailed market overview, market determinants, company profiling, market segmentation, geographical analysis, patent analysis, strategic recommendations, key company analysis, key findings, market estimations, market insights, analyst insights and predictive analysis of the market.

Competitive Insights

Major players in the market include Abbot Laboratories, Bristol Myers Squibb Co., Johnson & Johnson, Pfizer, Amgen, Biogen IDEC, Celgine Corporation, Merck & Co., Inc., Gilead Sciences Inc., Eli Lilly and Co, Astra Zeneca, Sanofi Aventis SA, GlaxoSmithKline Plc, Roche Pharmaceuticals, Novartis AG, Bayer HealthCare AG, Toyama Chemical Co., Ltd, Astellas Pharma Inc., MiddleBrook Pharmaceuticals and Takeda Pharmaceutical Company.

Market Segmentation

Penicillin and streptomycin market by product:

  • Penicillin
    • Penicillin by bulk
    • Penicillin by dosage
  • Streptomycin
    • Streptomycin by bulk
    • Streptomycin by dosage

Penicillin and streptomycin market by manufacturing process:

  • Penicillin by synthetic process
  • Penicillin by natural process
  • Penicillin by semi-synthetic process
  • Streptomycin by synthetic process
  • Streptomycin by natural process
  • Streptomycin semi-synthetic process

Penicillin and streptomycin market by route of administration:

  • Penicillin by oral route of administration
  • Penicillin by intramuscular route of administration
  • Global penicillin by intravenous route of administration
  • Streptomycin by oral route of administration
  • Streptomycin by intramuscular route of administration
  • Streptomycin by intravenous route of administration

Penicillin and streptomycin market by end users market:

  • Hospitals
  • Clinics
  • Others

Report Coverage:

  • Comprehensive research methodology of Global Penicillin and Streptomycin Market.
  • This report also includes detailed and extensive market overview with gap analysis, historical analysis & key analyst’s insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Global Penicillin and Streptomycin Market.
  • Insights about market determinants which are stimulating the Global Penicillin and Streptomycin Market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbot Laboratories
  • Astra Zeneca
  • Bristol Myers Squibb Co.
  • Gilead Sciences Inc.
  • Merck & Co., Inc.
  • Roche Pharmaceuticals
  • MORE

1. Report Summary
    1.1. Research Methods and Tools
    1.2. Market Breakdown
        1.2.1. by Segments
        1.2.2. by Geography
        1.2.3. by Stakeholders

2. Market Overview and Insights
    2.1. Definition
    2.2. Current Market Trends
    2.3. Analyst Insight
        2.3.1. Key Findings
        2.3.2. Recommendation
        2.3.3. Conclusion
    2.4. Regulations for Drugs and Devices
        2.4.1. United States
        2.4.2. China
        2.4.3. India
        2.4.4. Rest of the World
    2.5. Patent Analysis

3. Market Determinant
    3.1. Motivators
        3.1.1. Growing Number of Infectious Diseases
        3.1.2. Rising Investments in Research and Development
        3.1.3. Increasing Demand for Generic Drugs
    3.2. Restraints
        3.2.1. Strict Government Regulations
        3.2.2. Increasing Incidences of Anti Microbial Resistance
        3.2.3. Patent Expiration
    3.3. Opportunities
        3.3.1. New Product Development
        3.3.2. Rising Usage of Penicillin -Streptomycin in Cell Culture

4. Market Segmentation
    4.1. Penicillin and Streptomycin Market by Product
        4.1.1. Penicillin
            4.1.1.1. Penicillin by Bulk
            4.1.1.2. Penicillin by Dosage
        4.1.2. Streptomycin
            4.1.2.1. Streptomycin by Bulk
            4.1.2.2. Streptomycin by Dosage
    4.2. Penicillin and Streptomycin Market by Manufacturing Process
        4.2.1. Penicillin by Synthetic Process
        4.2.2. Penicillin by Natural Process
        4.2.3. Penicillin by Semi-Synthetic Process
        4.2.4. Streptomycin by Synthetic Process
        4.2.5. Streptomycin by Natural Process
        4.2.6. Streptomycin Semi-Synthetic Process
    4.3. Penicillin and Streptomycin Market by Route of Administration
        4.3.1. Penicillin by Oral Route of Administraton
        4.3.2. Penicillin by Intramuscular Route of Administraton
        4.3.3. Global Penicillin by Intravenous Route of Administraton
        4.3.4. Streptomycin by Oral Route of Administration
        4.3.5. Streptomycin by Intramuscular Route of Administraton
        4.3.6. Streptomycin by Intravenous Route of Administraton
    4.4. Penicillin and Streptomycin Market by End Users Market
        4.4.1. Hospitals
        4.4.2. Clinics
        4.4.3. Others

5. Competitive Landscape
    5.1. Key Strategy Analysis
    5.2. Key Company Analysis

6. Regional Analysis
    6.1. North American
        6.1.1. United States
        6.1.2. Canada
        6.1.3. Rest of North America
    6.2. Europe
        6.2.1. United Kingdom
        6.2.2. France
        6.2.3. Germany
        6.2.4. Italy
        6.2.5. Spain
        6.2.6. Rest of Europe
    6.3. Asia Pacific
        6.3.1. India
        6.3.2. China
        6.3.3. Japan
        6.3.4. Rest of Asia Pacific
    6.4. Rest of the World

7. Company Profiles
    7.1. Abbot Laboratories
        7.1.1. Introduction
        7.1.2. Abbot Laboratories Product Portfolio
        7.1.3. Abbot Laboratories Recent Activities
    7.2. Amgen
        7.2.1. Introduction
        7.2.2. Amgen Product Portfolio
        7.2.3. Amgen Recent Activities
    7.3. Astellas Pharma Inc.
        7.3.1. Introduction
        7.3.2. Astellas Pharma Inc. Product Portfolio
        7.3.3. Astellas Pharma Inc. Recent Activities
    7.4. Astra Zeneca
        7.4.1. Introduction
        7.4.2. Astra Zeneca Product Portfolio
        7.4.3. Astra Zeneca Recent Activities
    7.5. Bayer Healthcare AG
        7.5.1. Introduction
        7.5.2. Bayer Healthcare AG Product Portfolio
        7.5.3. Bayer Healthcare AG Recent Activities
    7.6. Biogen IDEC
        7.6.1. Introduction
        7.6.2. Biogen IDEC Product Portfolio
        7.6.3. Biogen IDEC Recent Activities
    7.7. Bristol Myers Squibb Co.
        7.7.1. Introduction
        7.7.2. Bristol Myers Squibb Co. Product Portfolio
        7.7.3. Bristol Myers Squibb Co. Recent Activities
    7.8. Celgine Corporation
        7.8.1. Introduction
        7.8.2. Celgine Corporation Product Portfolio
        7.8.3. Celgine Corporation Recent Activities
    7.9. Eli Lilly and Co
        7.9.1. Introduction
        7.9.2. Eli Lilly and Co Product Portfolio
        7.9.3. Eli Lilly and Co Recent Activities
    7.10. Gilead Sciences Inc.
        7.10.1. Introduction
        7.10.2. Gilead Sciences Inc. Product Portfolio
        7.10.3. Gilead Sciences Inc. Recent Activities
    7.11. Glaxosmithkline Plc
        7.11.1. Introduction
        7.11.2. Glaxosmithkline Plc Product Portfolio
        7.11.3. Glaxosmithkline Plc Recent Activities
    7.12. Johnson & Johnson
        7.12.1. Introduction
        7.12.2. Johnson & Johnson Product Portfolio
        7.12.3. Johnson & Johnson Recent Activities
    7.13. Merck & Co., Inc.
        7.13.1. Introduction
        7.13.2. Merck & Co., Inc. Product Portfolio
        7.13.3. Merck & Co., Inc. Recent Activities
    7.14. Middlebrook Pharmaceuticals
        7.14.1. Introduction
        7.14.2. Middlebrook Pharmaceuticals Product Portfolio
        7.14.3. Middlebrook Pharmaceuticals Recent Activities
    7.15. Novartis AG
        7.15.1. Introduction
        7.15.2. Novartis AG Product Portfolio
        7.15.3. Novartis AG Recent Activities
    7.16. Pfizer
        7.16.1. Introduction
        7.16.2. Pfizer Product Portfolio
        7.16.3. Pfizer Recent Activities
    7.17. Roche Pharmaceuticals
        7.17.1. Introduction
        7.17.2. Roche Pharmaceuticals Product Portfolio
        7.17.3. Roche Pharmaceuticals Recent Activities
    7.18. Sanofi Aventis SA
        7.18.1. Introduction
        7.18.2. Sanofi Aventis SA Product Portfolio
        7.18.3. Sanofi Aventis SA Recent Activities
    7.19. Takeda Pharmaceutical Company
        7.19.1. Introduction
        7.19.2. Takeda Pharmaceutical Company Product Portfolio
        7.19.3. Takeda Pharmaceutical Company Recent Activities
    7.20. Toyama Chemical Co. Ltd
        7.20.1. Introduction
        7.20.2. Toyama Chemical Co. Ltd Product Portfolio
        7.20.3. Toyama Chemical Co. Ltd Recent Activities

List of Tables
Table 1 Global Penicillin and Streptomycin Market by Product, 2015-2022 ($ Million)
Table 2 Global Penicillin and Streptomycin Market, 2015-2022 ($ Million)
Table 3 Global Penicillin and Streptomycin Market, by Bulk, 2015-2022 ($ Million)
Table 4 Global Penicillin and Streptomycin Market, by Dosage, 2015-2022 ($ Million)
Table 5 Global Penicillin and Streptomycin Market by Manufacturing Process, 2015-2022 ($ Million)
Table 6 Global Penicillin and Streptomycin Market by Synthetic Process, 2015-2022 ($ Million)
Table 7 Global Penicillin and Streptomycin Market by Natural Process, 2015-2022 ($ Million)
Table 8 Global Penicillin and Streptomycin Market by Semi-Synthetic Process, 2015-2022 ($ Million)
Table 9 Global Penicillin and Streptomycin Market by Route of Administration, 2015-2022 ($ Million)
Table 10 Global Penicillin and Streptomycin Market by Oral Route of Administraton, 2015-2022 ($ Million)
Table 11 Global Penicillin and Streptomycin Market by Intramuscular Route of Administraton, 2015-2022 ($ Million)
Table 12 Global Penicillin and Streptomycin Market by Intravenous Route of Administraton, 2015-2022 ($ Million)
Table 13 Global Penicillin and Streptomycin Market by End Users Market, 2015-2022 ($ Million)
Table 14 Global Penicillin and Streptomycin Market by Hospitals, 2015-2022 ($ Million)
Table 15 Global Penicillin and Streptomycin Market by Clinics, 2015-2022 ($ Million)
Table 16 Global Penicillin and Streptomycin Market by Pharmaceuticals, 2015-2022 ($ Million)
Table 17 Abbot Laboratories Product Portfolio
Table 18 Abbot Laboratories Recent Activities
Table 19 Abbot Laboratories SWOT Analysis
Table 20 Amgen Product Portfolio
Table 21 Amgen Recent Activities
Table 22 Astellas Pharma Inc. Product Portfolio
Table 23 Astellas Pharma Inc. Recent Activities
Table 24 Astra Zeneca Product Portfolio
Table 25 Astra Zeneca Recent Activities
Table 26 Bayer Healthcare Ag Product Portfolio
Table 27 Bayer Healthcare Ag Recent Activities
Table 28 Biogen Idec Product Portfolio
Table 29 Biogen Idec Recent Activities
Table 30 Bristol Myers Squibb Co. Product Portfolio
Table 31 Bristol Myers Squibb Co. Recent Activities
Table 32 Bristol Myers Squibb Co. SWOT Analysis
Table 33 Celgine Corporation Product Portfolio
Table 34 Celgine Corporation Recent Activities
Table 35 Eli Lilly and Co Product Portfolio
Table 36 Eli Lilly and Co Recent Activities
Table 37 Gilead Sciences Inc. Product Portfolio
Table 38 Gilead Sciences Inc. Recent Activities
Table 39 Glaxosmithkline Plc Product Portfolio
Table 40 Glaxosmithkline Plc Recent Activities
Table 41 Johnson & Johnson Product Portfolio
Table 42 Johnson & Johnson Recent Activities
Table 43 Merck & Co., Inc. Product Portfolio
Table 44 Merck & Co., Inc. Recent Activities
Table 45 Middlebrook Pharmaceuticals Product Portfolio
Table 46 Middlebrook Pharmaceuticals Recent Activities
Table 47 Novartis Ag Product Portfolio
Table 48 Novartis Ag Recent Activities
Table 49 Pfizer Product Portfolio
Table 50 Pfizer Recent Activities
Table 51 Roche Pharmaceuticals Product Portfolio
Table 52 Roche Pharmaceuticals Recent Activities
Table 53 Roche Pharmaceuticals SWOT Analysis
Table 54 Sanofi Aventis Sa Product Portfolio
Table 55 Sanofi Aventis Sa Recent Activities
Table 56 Takeda Pharmaceutical Company Product Portfolio
Table 57 Takeda Pharmaceutical Company Recent Activities
Table 58 Toyama Chemical Co. Ltd Product Portfolio
Table 59 Toyama Chemical Co. Ltd Recent Activities

List of Figures
Figure 1 North American Market Research and Analysis, 2015-2022
Figure 2 United States Market Research and Analysis, 2015-2022
Figure 3 Canada Market Research and Analysis, 2015-2022
Figure 4 European Market Research and Analysis, 2015-2022
Figure 5 United Kingdom Market Research and Analysis, 2015-2022
Figure 6 France Market Research and Analysis, 2015-2022
Figure 7 Germany Market Research and Analysis, 2015-2022
Figure 8 Roe Market Research and Analysis, 2015-2022
Figure 9 Asia Pacific Market Research and Analysis, 2015-2022
Figure 10 India Market Research and Analysis, 2015-2022
Figure 11 China Market Research and Analysis, 2015-2022
Figure 12 Japan Market Research and Analysis, 2015-2022
Figure 13 Ropac Market Research and Analysis, 2015-2022
Figure 14 Rest of the World Market Research and Analysis, 2015-2022

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Abbot Laboratories
  • Amgen
  • Astellas Pharma Inc.
  • Astra Zeneca
  • Bayer HealthCare AG
  • Biogen IDEC
  • Bristol Myers Squibb Co.
  • Celgine Corporation
  • Eli Lilly and Co
  • Gilead Sciences Inc.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • MiddleBrook Pharmaceuticals
  • Novartis AG
  • Pfizer
  • Roche Pharmaceuticals
  • Sanofi Aventis SA
  • Takeda Pharmaceutical Company
  • Toyama Chemical Co., Ltd
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll